Company Filing History:
Years Active: 2019-2021
Title: Innovations in Eye Disease Treatment by Keith Roizman
Introduction
Keith Roizman is an accomplished inventor based in San Jose, CA, known for his significant contributions to the field of ophthalmology. He has been instrumental in developing innovative therapeutic agents aimed at treating age-related macular degeneration (AMD) and other eye diseases. With a total of 2 patents, Roizman's work is paving the way for new treatment options in eye care.
Latest Patents
Roizman's latest patents focus on the topical delivery of therapeutic agents using cell-penetrating peptides. These agents are designed for the treatment of age-related macular degeneration and other eye disorders. The first patent outlines a method for administering therapeutic agents that can target various stages and phenotypes of AMD, including geographic atrophy and neovascularization. The second patent introduces apolipoprotein mimetics that mimic the lipid-clearing action of apolipoproteins, providing additional benefits such as reducing inflammation and oxidative stress.
Career Highlights
Roizman is currently associated with Macregen, Inc., where he continues to innovate in the field of eye care. His work has garnered attention for its potential to improve the quality of life for individuals suffering from age-related eye diseases.
Collaborations
One of his notable collaborators is John Jacob Requard, III, with whom he has worked closely on various projects aimed at advancing therapeutic solutions for eye disorders.
Conclusion
Keith Roizman's contributions to the field of ophthalmology through his innovative patents are significant. His work not only addresses critical health issues but also opens new avenues for research and development in eye care.